{"content":"<li class=\"n-box-item date-title\" data-end=\"1507607999\" data-start=\"1507521600\" data-txt=\"Monday, December 23, 2019\">Monday, October  9, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3300056\" data-ts=\"1507591318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CPB\" target=\"_blank\">CPB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300056-campbell-soup-names-fraga-to-lead-global-functions\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Campbell Soup names Fraga to lead global IT functions</a></h4><ul>   <li>Campbell Soup (<a href=\"http://seekingalpha.com/symbol/CPB\" target=\"_blank\">CPB</a> <font color='red'>-2.1%</font>) has named Francisco Fraga VP and <a href=\"https://seekingalpha.com/pr/16963187-campbell-appoints-francisco-fraga-chief-technology-information-officer\" target=\"_blank\">chief technology and information officer</a>.</li>    <li>He'll oversee global IT for the company.</li>    <li>He's joining from Procter &amp; Gamble after spending 21 years there in various roles -- most recently as IT Global chief technology officer.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3300056\" data-linked=\"Campbell Soup names Fraga to lead global IT functions\" data-tweet=\"$CPB - Campbell Soup names Fraga to lead global IT functions https://seekingalpha.com/news/3300056-campbell-soup-names-fraga-to-lead-global-functions?source=tweet\" data-url=\"https://seekingalpha.com/news/3300056-campbell-soup-names-fraga-to-lead-global-functions\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300051\" data-ts=\"1507585039\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300051-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/ICHR' title='Ichor Holdings, Ltd.'>ICHR</a> <font color='green'>+6.3%</font>. <a href='https://seekingalpha.com/symbol/TIVO' title='TiVo Inc.'>TIVO</a> <font color='green'>+2.8%</font>. <a href='https://seekingalpha.com/symbol/ALT' title='Altimmune, Inc.'>ALT</a> <font color='green'>+2.3%</font>. <a href='https://seekingalpha.com/symbol/INAP' title='Internap Network Services Corporation'>INAP</a> <font color='green'>+2.0%</font>. <a href='https://seekingalpha.com/symbol/VSAR-OLD' title='Versartis, Inc.'>VSAR-OLD</a> <font color='green'>+1.9%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/EXEL' title='Exelixis, Inc.'>EXEL</a> <font color='red'>-1.6%</font>. <a href='https://seekingalpha.com/symbol/KL' title='Kirkland Lake Gold Ltd.'>KL</a> <font color='red'>-1.3%</font>. <a href='https://seekingalpha.com/symbol/AIG' title='American International Group Inc'>AIG</a> <font color='red'>-1.3%</font>. <a href='https://seekingalpha.com/symbol/FLXN' title='Flexion Therapeutics, Inc.'>FLXN</a> <font color='red'>-1.2%</font>. <a href='https://seekingalpha.com/symbol/NBL' title='Noble Energy, Inc.'>NBL</a> <font color='red'>-1.1%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3300051\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$ICHR $TIVO $ALT - After Hours Gainers / Losers https://seekingalpha.com/news/3300051-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3300051-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300047\" data-ts=\"1507581007\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICHR\" target=\"_blank\">ICHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300047-ichor-holdings-up-5-on-sales-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ichor Holdings up 5% on sales deal</a></h4><ul><li>The company <a href=\"http://ir.ichorsystems.com/phoenix.zhtml?c=254467&amp;p=irol-newsArticle&amp;ID=2305490\" target=\"_blank\">has inked a deal</a> for the design and manufacture of its proprietary Liquid Delivery Systems to be integrated with the semiconductor process equipment for one of its key customers.</li><li><a href='https://seekingalpha.com/symbol/ICHR' title='Ichor Holdings, Ltd.'>ICHR</a>&nbsp;<font color='green'>+5%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3300047\" data-linked=\"Ichor Holdings up 5% on sales deal\" data-tweet=\"$ICHR - Ichor Holdings up 5% on sales deal https://seekingalpha.com/news/3300047-ichor-holdings-up-5-on-sales-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3300047-ichor-holdings-up-5-on-sales-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300037\" data-ts=\"1507579181\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SGRY\" target=\"_blank\">SGRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300037-surgery-partners-down-13-on-bofa-price-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Surgery Partners down 13% on BofA price cut</a></h4><ul><li>Surgery Partners (<a href='https://seekingalpha.com/symbol/SGRY' title='Surgery Partners, Inc.'>SGRY</a> <font color='red'>-12.6%</font>) is under pressure on below average volume on the heels of a target price revision to $19 from $23 by Bank of America (BUY rating maintained).</li><li>Shares were in a modest clawback after plummeting in August after its Q2 miss.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3287600-surgery-partners-35-percent-ugly-q2-lowered-guidance\" target=\"_blank\">Surgery Partners down 35% after ugly Q2, lowered guidance</a> (Aug. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3300037\" data-linked=\"Surgery Partners down 13% on BofA price cut\" data-tweet=\"$SGRY - Surgery Partners down 13% on BofA price cut https://seekingalpha.com/news/3300037-surgery-partners-down-13-on-bofa-price-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3300037-surgery-partners-down-13-on-bofa-price-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300036\" data-ts=\"1507578822\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300036-dividend-cut-on-way-ge\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dividend cut on the way at GE?</a></h4><ul><li>The&nbsp; chance of a dividend cut has moved \"materially higher,\" <a href=\"http://www.barrons.com/articles/general-electric-after-ousters-a-dividend-cut-1507564538?mod=hp_RTA&amp;\" target=\"_blank\">says noted</a> General Electric (NYSE:<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a>) bear, JPMorgan's Stephen Tusa.</li><li>The bulls, of course, will say that GE's significant housecleaning is a show of strength, but Tusa wonders why CFO Jeffrey Bornstein was kept around so long, noting that as recently as mid-September, Bornstein was though to be part of the fix for GE (he notes Bornstein and two other exiting execs were all given retention bonuses last summer).</li><li>GE shares continue to act poorly following the moves,&nbsp;<font color='red'>down 4.2%&nbsp;</font>on the session.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3299959-general-electric-3-percent-management-shake\" target=\"_blank\">General Electric down 3% after management shake-up</a> (Oct. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3300036\" data-linked=\"Dividend cut on the way at GE?\" data-tweet=\"$GE - Dividend cut on the way at GE? https://seekingalpha.com/news/3300036-dividend-cut-on-way-ge?source=tweet\" data-url=\"https://seekingalpha.com/news/3300036-dividend-cut-on-way-ge\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>111&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300035\" data-ts=\"1507578469\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRNS\" target=\"_blank\">MRNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300035-profit-taking-pressures-marinus-shares-down-27-in-two-days\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Profit-taking pressures Marinus; shares down 27% in two days</a></h4><ul><li>Investors in Marinus Pharmaceuticals (<a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a> <font color='red'>-18.6%</font>) appear to be taking money off the table. Shares, down on more than double normal volume, have corrected 27% since Thursday. The action is predictable considering the stock's more than six-fold runup since mid-July.</li><li>One event boosting demand was positive mid-stage results on lead candidate ganaxolone in a rare neurological disorder called CDKL5.</li><li>Another Phase 2 study in women with severe postpartum depression is in process with topline data expected this quarter.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3294604-marinus-pharmas-ganaxolone-shows-treatment-effect-mid-stage-study-rare-seizure-disorder\" target=\"_blank\">Marinus Pharma's ganaxolone shows treatment effect in mid-stage study in rare seizure disorder; shares ahead 28% premarket</a> (Sept. 11)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3275758-marinus-launches-mid-stage-study-ganaxolone-iv-women-ppd\" target=\"_blank\">Marinus launches mid-stage study of ganaxolone IV in women with PPD</a> (June 27)</li></ul><div class=\"tiny-share-widget\" data-id=\"3300035\" data-linked=\"Profit-taking pressures Marinus; shares down 27% in two days\" data-tweet=\"$MRNS - Profit-taking pressures Marinus; shares down 27% in two days https://seekingalpha.com/news/3300035-profit-taking-pressures-marinus-shares-down-27-in-two-days?source=tweet\" data-url=\"https://seekingalpha.com/news/3300035-profit-taking-pressures-marinus-shares-down-27-in-two-days\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>98&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300034\" data-ts=\"1507578165\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300034-box-office-weak-blade-runner-slip-star-wars-is-lining-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Box office weak with &#39;Blade Runner&#39; slip, but &#39;Star Wars&#39; is lining up</a></h4><ul>   <li><i>Blade Runner 2049</i> (<a href=\"http://seekingalpha.com/symbol/TWX\" target=\"_blank\">TWX</a> <font color='red'>-0.1%</font>) may have <a href=\"https://seekingalpha.com/news/3299978-theater-stocks-retreat-blade-runner-debut-falls-short\" target=\"_blank\">stumbled out of the box office gate</a>, disappointing expectations with a $32.8M opening, but other studios didn't put up much of a fight.</li>    <li>The Warner Bros. sci-fi sequel prevailed over a counter-programmed drama from Fox (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='red'>-1.6%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='red'>-1.4%</font>), <i>The Mountain Between Us,</i> which mustered $10.1M for second place, ahead of the fifth weekend of Warner's horror hit <i>It,</i> which drew $9.97M.</li>    <li>Another newcomer, <i>My Little Pony: The Movie</i> (<a href='https://seekingalpha.com/symbol/LGF.A' title='Lions Gate Entertainment Corp.'>LGF.A</a> <font color='red'>-1%</font>, <a href='https://seekingalpha.com/symbol/LGF.B' title='Lions Gate Entertainment Corp.'>LGF.B</a> <font color='red'>-0.4%</font>), took the fourth spot with $8.8M, just ahead of <i>Kingsman: The Golden Circle</i> (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a>) with $8.1M; <i>American Made</i> (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='red'>-0.6%</font>), with $8.07M; and <i>The LEGO Ninjago Movie</i> (NYSE:<a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a>), with $7M.</li>    <li><i>It</i> has now hit $305M domestically, and $604M worldwide, which means it's about to break into the worldwide top 10 for 2017 (it's just behind <i>Transformers: The Last Knight,</i> with $605.4M in worldwide grosses).</li>    <li>Meanwhile, expectations were high for the first day of advance ticket sales for <i>Star Wars: The Last Jedi</i> (<a href=\"http://seekingalpha.com/symbol/DIS\" target=\"_blank\">DIS</a> <font color='red'>-0.5%</font>), expected to begin after a new trailer at halftime of Monday Night Football. The film is set for a mid-December release but should bank huge sums before the night is up.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3300034\" data-linked=\"Box office weak with &#39;Blade Runner&#39; slip, but &#39;Star Wars&#39; is lining up\" data-tweet=\"$FOX $FOX $FOXA - Box office weak with &#39;Blade Runner&#39; slip, but &#39;Star Wars&#39; is lining up https://seekingalpha.com/news/3300034-box-office-weak-blade-runner-slip-star-wars-is-lining-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3300034-box-office-weak-blade-runner-slip-star-wars-is-lining-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300033\" data-ts=\"1507577580\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NSPR\" target=\"_blank\">NSPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300033-study-commences-in-russia-comparing-inspiremds-cguard-to-abbotts-rx-acculink-shares-up-19\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Study commences in Russia comparing InspireMD&#39;s CGuard to Abbott&#39;s RX Acculink; shares up 19%</a></h4><ul><li>An investigator-initiated study is underway in Russia that will compare the neuro-protection and clinic performance of InspireMD's (<a href='https://seekingalpha.com/symbol/NSPR' title='InspireMD, Inc.'>NSPR</a> <font color='green'>+18.9%</font>) <a href=\"http://www.inspiremd.com/en/product/cguard/\" target=\"_blank\">CGuard Embolic Prevention System</a> against Abbott's (<a href='https://seekingalpha.com/symbol/ABT' title='Abbott Laboratories'>ABT</a> <font color='red'>-0.5%</font>) RX Acculink Carotid Stent System in patients at high risk of <a href=\"https://en.wikipedia.org/wiki/Carotid_endarterectomy\" target=\"_blank\">carotid endarterectomy</a> (the removal of material from the inside of an artery).</li><li>The 100-subject study will be conducted at Novosibirsk State University's Scientific Research Institute of Circulation Pathology led by Professor Andrei Karpenko. The primary endpoint is new ischemic areas in the brain with 24 to 48 hours after the procedure and new lesion permanence at day 30 as determined by MRI. All patients will receive clinical and ultrasound follow-up at one year.</li><li>InspireMD says CGuard is designed to prevent embolization (blocking a blood vessel) by trapping potential emboli against the arterial wall while maintaining excellent blood flow.</li></ul><div class=\"tiny-share-widget\" data-id=\"3300033\" data-linked=\"Study commences in Russia comparing InspireMD&#39;s CGuard to Abbott&#39;s RX Acculink; shares up 19%\" data-tweet=\"$NSPR $NSPR $ABT - Study commences in Russia comparing InspireMD&#39;s CGuard to Abbott&#39;s RX Acculink; shares up 19% https://seekingalpha.com/news/3300033-study-commences-in-russia-comparing-inspiremds-cguard-to-abbotts-rx-acculink-shares-up-19?source=tweet\" data-url=\"https://seekingalpha.com/news/3300033-study-commences-in-russia-comparing-inspiremds-cguard-to-abbotts-rx-acculink-shares-up-19\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300031\" data-ts=\"1507575988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CAKE\" target=\"_blank\">CAKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300031-cheesecake-factory-rallies-after-hedgeye-flips-script\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cheesecake Factory rallies after Hedgeye flips the script</a></h4><ul><li>Cheesecake Factory (NASDAQ:<a href='https://seekingalpha.com/symbol/CAKE' title='The Cheesecake Factory Incorporated'>CAKE</a>)&nbsp;<font color='green'>jumps 1.6%</font>&nbsp;after landing on Hedgeye's list of favorite long ideas.</li><li>A sharp drop in Cheesecake's share priced flipped Hedgeye's view on valuation.</li><li>Cheesecake Factory hit a 52-week low of $38.34 last month.</li></ul><div class=\"tiny-share-widget\" data-id=\"3300031\" data-linked=\"Cheesecake Factory rallies after Hedgeye flips the script\" data-tweet=\"$CAKE - Cheesecake Factory rallies after Hedgeye flips the script https://seekingalpha.com/news/3300031-cheesecake-factory-rallies-after-hedgeye-flips-script?source=tweet\" data-url=\"https://seekingalpha.com/news/3300031-cheesecake-factory-rallies-after-hedgeye-flips-script\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300028\" data-ts=\"1507575368\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300028-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='green'>+37%</font>. <a href='https://seekingalpha.com/symbol/SMSI' title='Smith Micro Software, Inc.'>SMSI</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/CCIH' title='ChinaCache International'>CCIH</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/INTT' title='inTest Corporation'>INTT</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/GRVY' title='GRAVITY Co., Ltd. - American depositary shares, each representing one'>GRVY</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/NETE' title='Net Element International, Inc.'>NETE</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/LOV' title='Spark Networks, Inc'>LOV</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/PTI' title='Proteostasis Therapeutics'>PTI</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3300028\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$HMNY $SMSI $LEDS - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3300028-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3300028-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300027\" data-ts=\"1507575011\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWX\" target=\"_blank\">TWX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300027-report-doj-review-of-and-t-time-warner-slowing-new-antitrust-chief\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: DOJ review of AT&amp;T/Time Warner slowing with new antitrust chief</a></h4><ul>   <li>Shares in Time Warner (NYSE:<a href='https://seekingalpha.com/symbol/TWX' title='Time Warner Inc.'>TWX</a>), marking a gain for much of the day, have slipped back a few pennies into negative ground on word that a Justice Dept. review of its $85B buyout by AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color='red'>-1%</font>) is slowing down now that antitrust chief Makan Delrahim is in place.</li>    <li>Capitol Forum is reporting that Delrahim asked for more time to get up to speed on the deal, now that he has access to documents and data the staff had before.</li>    <li>Talks between the department and AT&amp;T and Time Warner are ongoing with several key points unresolved for now, Bloomberg says.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3298043-senate-confirms-antitrust-chief-queueing-deal-discussions\" target=\"_blank\">Senate confirms antitrust chief, queueing up deal discussions</a> (Sep. 27 2017)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3290267-wsj-t-hitting-time-warner-deal-milestone-talks-doj\" target=\"_blank\">WSJ: AT&amp;T hitting Time Warner deal milestone in talks with DOJ</a> (Aug. 17 2017)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3300027\" data-linked=\"Report: DOJ review of AT&amp;T/Time Warner slowing with new antitrust chief\" data-tweet=\"$TWX $TWX $T - Report: DOJ review of AT&amp;T/Time Warner slowing with new antitrust chief https://seekingalpha.com/news/3300027-report-doj-review-of-and-t-time-warner-slowing-new-antitrust-chief?source=tweet\" data-url=\"https://seekingalpha.com/news/3300027-report-doj-review-of-and-t-time-warner-slowing-new-antitrust-chief\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>55&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300026\" data-ts=\"1507574511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNSL\" target=\"_blank\">KNSL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300026-kinsale-capital-down-8_4-bull-rings-register\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kinsale Capital down 8.4% as a bull rings the register</a></h4><ul><li>Kinsale Capital (NASDAQ:<a href='https://seekingalpha.com/symbol/KNSL' title='Kinsale Capital Group, Inc.'>KNSL</a>) has more than doubled since its IPO just over a year ago, but it's&nbsp;<font color='red'>down 8.4%</font>&nbsp;today after William Blair's Adam Klauber suggests taking profits.</li><li>He remains a long-term bull, suggesting the company will double in size in the next four or five years. Klauber downgrades to Market Perform.</li></ul><div class=\"tiny-share-widget\" data-id=\"3300026\" data-linked=\"Kinsale Capital down 8.4% as a bull rings the register\" data-tweet=\"$KNSL - Kinsale Capital down 8.4% as a bull rings the register https://seekingalpha.com/news/3300026-kinsale-capital-down-8_4-bull-rings-register?source=tweet\" data-url=\"https://seekingalpha.com/news/3300026-kinsale-capital-down-8_4-bull-rings-register\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300020\" data-ts=\"1507572105\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300020-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/DELT' title='Delta Technology Holdings Limited'>DELT</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/HLX' title='Helix Energy Solutions Group, Inc.'>HLX</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/ZN' title='Zion Oil & Gas Inc'>ZN</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/PFIE' title='Profire Energy, Inc.'>PFIE</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SID' title='Companhia Siderurgica Nacional'>SID</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3300020\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$DELT-OLD $LGCY $HLX - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3300020-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3300020-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300017\" data-ts=\"1507571278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCOI\" target=\"_blank\">CCOI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300017-cogent-communicationsminus-4_7-after-wells-downgrades-to-neutral\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cogent Communications -4.7% after Wells downgrades to Neutral</a></h4><ul>   <li>Wells Fargo has gone to Market Perform on Cogent Communications (<a href=\"http://seekingalpha.com/symbol/CCOI\" target=\"_blank\">CCOI</a> <font color='red'>-4.7%</font>), saying the telecom has a tougher road to its goal of 10-20% long-term revenue growth.</li>    <li>The company's netcentric business segment needs to speed up to achieve that, notes analyst Jennifer Fritzsche -- to 8% growth vs. Wells' 2017 estimate of 5.7%.</li>    <li>If that doesn't happen, then the corporate revenue growth needs to accelerate, she says (h/t Bloomberg)</li>    <li>The firm has updated its price target to $48 from $46; shares are currently down to $48.45.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3300017\" data-linked=\"Cogent Communications -4.7% after Wells downgrades to Neutral\" data-tweet=\"$CCOI - Cogent Communications -4.7% after Wells downgrades to Neutral https://seekingalpha.com/news/3300017-cogent-communicationsminus-4_7-after-wells-downgrades-to-neutral?source=tweet\" data-url=\"https://seekingalpha.com/news/3300017-cogent-communicationsminus-4_7-after-wells-downgrades-to-neutral\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300016\" data-ts=\"1507570991\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HLX\" target=\"_blank\">HLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300016-wsj-helix-energy-exploring-options-shares-jump-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WSJ: Helix Energy exploring options; shares jump 7%</a></h4><ul><li>The Houston-based offshore energy company is working with bankers on a potential sale, <a href=\"https://www.wsj.com/articles/helix-energy-solutions-exploring-strategic-alternatives-1507570680?tesla=y\" target=\"_blank\">reports Dana Mattioli</a>. Should a deal happen, it would be the latest in a consolidating oil-field services industry.</li><li><a href='https://seekingalpha.com/symbol/HLX' title='Helix Energy Solutions Group, Inc.'>HLX</a><font color='green'> +7.1%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3300016\" data-linked=\"WSJ: Helix Energy exploring options; shares jump 7%\" data-tweet=\"$HLX - WSJ: Helix Energy exploring options; shares jump 7% https://seekingalpha.com/news/3300016-wsj-helix-energy-exploring-options-shares-jump-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3300016-wsj-helix-energy-exploring-options-shares-jump-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300015\" data-ts=\"1507570843\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YELP\" target=\"_blank\">YELP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300015-yelpminus-2_4-cantor-sees-positives-reflected-in-current-price\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Yelp -2.4% as Cantor sees positives reflected in current price</a></h4><ul>   <li>Coming off a 52-week high Friday, Yelp (NYSE:<a href='https://seekingalpha.com/symbol/YELP' title='Yelp'>YELP</a>) is <font color='red'>2.4% lower</font> as Cantor Fitzgerald downgrades to Neutral, seeing all the positives now baked in.</li>    <li>Shares are <font color='green'>up 32.7%</font> in 2017, but they're <font color='green'>up 41%</font> just over the past couple of months. At $45.61 currently, the firm believes it's fairly valued compared to a discounted cash flow-derived target of $44.</li>    <li><a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/10/10155548/yelps-valuation-earns-a-poor-review-with-this-analyst\" target=\"_blank\">Ad revenue growth is healthy</a>, and Cantor expects contributions from the national and self-serve channels to continue growing.</li>    <li>But: \"While retention/churn has improved with client partner team retention efforts, it's important to note that quarterly SMB local ad revenue could remain choppy in any given quarter as a result of these factors,\" the firm says.</li>    <li>It adds the partnership with GrubHub (NYSE:<a href='https://seekingalpha.com/symbol/GRUB' title='GrubHub Inc.'>GRUB</a>) could boost transaction revenues, with a 25% gain expected; food orders on Yelp were up 50% Y/Y in Q2.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3300015\" data-linked=\"Yelp -2.4% as Cantor sees positives reflected in current price\" data-tweet=\"$YELP $YELP $GRUB - Yelp -2.4% as Cantor sees positives reflected in current price https://seekingalpha.com/news/3300015-yelpminus-2_4-cantor-sees-positives-reflected-in-current-price?source=tweet\" data-url=\"https://seekingalpha.com/news/3300015-yelpminus-2_4-cantor-sees-positives-reflected-in-current-price\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300013\" data-ts=\"1507569652\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300013-natural-gas-continues-seasons-lows-warm-weather-sticks-around\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas continues at season&#39;s lows as warm weather sticks around</a></h4><ul><li>Unseasonably warm temps continue across the East Coast and Southeast, thus offsetting any positive impact to natural gas prices that may have seen from a drop in production amid Hurricane Nate.</li><li>The forecast: NYC is seen hitting 77 degrees in one week - 13 degrees above the normal high.</li><li><a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>&nbsp;<font color='red'>-1%</font></li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>, <a href='https://seekingalpha.com/symbol/DCNG' title='iPath Pure Beta Seasonal Natural Gas ETN'>DCNG</a>, <a href='https://seekingalpha.com/symbol/GAZB' title='iPath Series B Bloomberg Natural Gas Subindex Total Return ETN'>GAZB</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3300013\" data-linked=\"Natural gas continues at season&#39;s lows as warm weather sticks around\" data-tweet=\"$UNG $UGAZ $DGAZ - Natural gas continues at season&#39;s lows as warm weather sticks around https://seekingalpha.com/news/3300013-natural-gas-continues-seasons-lows-warm-weather-sticks-around?source=tweet\" data-url=\"https://seekingalpha.com/news/3300013-natural-gas-continues-seasons-lows-warm-weather-sticks-around\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300012\" data-ts=\"1507569175\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASY\" target=\"_blank\">CASY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300012-grocery-names-skittish-over-amazon-whole-foods-again\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Grocery names skittish over Amazon-Whole Foods again</a></h4><ul> <li>Grocery store stocks start the week off on a down note after Barclays warns on the impact of Amazon.</li> <li>Though the Barclays thesis isn't anything new, analyst Karen Short issues a more dire assessment on the sector than what most other analysts have published..</li> <li>She writes that most grocers lack \"scale, sophistication and the balance sheet in order to make the necessary investments\" and maintains that no food retailer will be left unscathed from the Amazon-Whole Foods evolution (per Bloomberg).</li> <li>In a broad look at grocery-related stocks -- Casey's General Stores (<a href='https://seekingalpha.com/symbol/CASY' title='Casey&#39;s General Stores, Inc.'>CASY</a> <font color='red'>-1.1%</font>), Kroger (<a href='https://seekingalpha.com/symbol/KR' title='Kroger Co.'>KR</a> <font color='red'>-1.9%</font>), Supervalu (<a href='https://seekingalpha.com/symbol/SVU' title='SUPERVALU Inc.'>SVU</a> <font color='red'>-3.1%</font>), Ingles Markets (<a href='https://seekingalpha.com/symbol/IMKTA' title='Ingles Markets, Incorporated'>IMKTA</a> <font color='red'>-2.6%</font>), Weis Markets (<a href='https://seekingalpha.com/symbol/WMK' title='Weis Markets Inc'>WMK</a> <font color='red'>-4.2%</font>), Core-Mark (<a href='https://seekingalpha.com/symbol/CORE' title='Core-Mark Holding Company, Inc.'>CORE</a> <font color='red'>-1.6%</font>), Smart &amp; Final Stores (<a href='https://seekingalpha.com/symbol/SFS' title='Smart & Final Stores'>SFS</a> <font color='red'>-7.1%</font>), iFresh (<a href='https://seekingalpha.com/symbol/IFMK' title='iFresh Inc.'>IFMK</a> <font color='red'>-3.1%</font>), Sprouts Farmers Market (<a href='https://seekingalpha.com/symbol/SFM' title='Sprouts Farmers Market'>SFM</a> <font color='red'>-1.9%</font>), Costco (<a href='https://seekingalpha.com/symbol/COST' title='Costco Wholesale Corporation'>COST</a> <font color='red'>-1.8%</font>), Blue Apron (<a href='https://seekingalpha.com/symbol/APRN' title='Blue Apron Holdings, Inc.'>APRN</a> <font color='red'>-1.5%</font>) and Target (<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a> <font color='red'>-0.8%</font>) are all swinging lower today.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3300012\" data-linked=\"Grocery names skittish over Amazon-Whole Foods again\" data-tweet=\"$CASY $CASY $KR - Grocery names skittish over Amazon-Whole Foods again https://seekingalpha.com/news/3300012-grocery-names-skittish-over-amazon-whole-foods-again?source=tweet\" data-url=\"https://seekingalpha.com/news/3300012-grocery-names-skittish-over-amazon-whole-foods-again\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>76&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300011\" data-ts=\"1507568448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300011-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OMF' title='OneMain Holdings, Inc.'>OMF</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a> <font color='green'>+10%</font>.<a href='https://seekingalpha.com/symbol/RTNB' title='root9B Technologies, Inc.'>OTC:RTNB</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/NOAH' title='Noah Holdings Limited'>NOAH</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/KCAP' title='KCAP Financial'>KCAP</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/OZM' title='Och-Ziff Capital Management Group LLC'>OZM</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/JTPY' title='JetPay Corporation'>JTPY</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3300011\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$OMF $JP $RTNB - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3300011-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3300011-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300008\" data-ts=\"1507567584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300008-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> CLNT <font color='green'>+113%</font>. <a href='https://seekingalpha.com/symbol/BSPM' title='Biostar Pharmaceutic'>OTC:BSPM</a> <font color='green'>+45%</font>. <a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a> <font color='green'>+32%</font>. <a href='https://seekingalpha.com/symbol/SMSI' title='Smith Micro Software, Inc.'>SMSI</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/ATEC' title='Alphatec Holdings, Inc.'>ATEC</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/SIFY' title='Sify Technologies Limited'>SIFY</a> <font color='green'>+17%</font>. BIOP <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/CCIH' title='ChinaCache International'>CCIH</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/KTWO' title='K2M Group Holdings, Inc.'>KTWO</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/LINU-OLD' title='LiNiu Technology Group'>LINU-OLD</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/NETE' title='Net Element International, Inc.'>NETE</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/NVIV' title='InVivo Therapeutics Holdings Corp'>NVIV</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/XXII' title='22nd Century Group, Inc.'>XXII</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ECYT' title='Endocyte, Inc.'>ECYT</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/TEAR' title='TearLab Corporation'>TEAR</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/SGRY' title='Surgery Partners, Inc.'>SGRY</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/DVA' title='DaVita HealthCare Partners Inc.'>DVA</a>&nbsp;<font color='red'>-9%</font></li> </ul><div class=\"tiny-share-widget\" data-id=\"3300008\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$SEII $BSPM $ONTX - Midday Gainers / Losers https://seekingalpha.com/news/3300008-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3300008-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300007\" data-ts=\"1507567180\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VERI\" target=\"_blank\">VERI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300007-veritoneplus-8_5-ceo-defends-shares-undervalued\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veritone +8.5% as CEO defends shares as undervalued</a></h4><ul>   <li>Pummeled recently by a short attack from Andrew Left and Citron Research, Veritone (<a href=\"http://seekingalpha.com/symbol/VERI\" target=\"_blank\">VERI</a> <font color='green'>+8.5%</font>) is rebounding today as it fights back saying it's not only not a short candidate -- it's still a cheap stock.</li>    <li>The roller coaster ride began in late August, where the stock ran from $7.87 on Aug. 18 to $65.91 by Sept. 26.</li>    <li>The next day, a <a href=\"https://seekingalpha.com/news/3297980-veritone-slides-citron-says-stock-70-percent-lower\" target=\"_blank\">tweet from Citron research</a> said the stock was 70% overvalued, and that the company wasn't \"artificial intelligence, more like natural stupidity.\" Shares <font color='red'>fell 30%</font>.</li>    <li>But there's still room to run as the <a href=\"https://www.bloomberg.com/news/articles/2017-10-09/citron-target-veritone-says-stock-isn-t-a-short-it-s-too-cheap\" target=\"_blank\">market opportunity for Veritone is huge</a>, says co-founder and CEO Chad Steelberg. &ldquo;Our general solution can be applied to so many problems,&rdquo; he tells Bloomberg. &ldquo;It clearly shows that our stock is undervalued given the use cases being leveraged by our partners.&rdquo;</li>    <li>&ldquo;The technology is absolutely flipping transformative,&rdquo; Roth Capital's Brian Alger tells Bloomberg.</li>    <li>A test is coming with an initial offering lockup expiring Nov. 8; insiders sitting on gains may sell, and more shares will be available for short sellers to borrow (about 3.1M of 15M shares outstanding are available to trade today).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3300007\" data-linked=\"Veritone +8.5% as CEO defends shares as undervalued\" data-tweet=\"$VERI - Veritone +8.5% as CEO defends shares as undervalued https://seekingalpha.com/news/3300007-veritoneplus-8_5-ceo-defends-shares-undervalued?source=tweet\" data-url=\"https://seekingalpha.com/news/3300007-veritoneplus-8_5-ceo-defends-shares-undervalued\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:39 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3300001\" data-ts=\"1507565747\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEAS\" target=\"_blank\">SEAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3300001-seaworld-rallies-again-on-elevated-calls-buying\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SeaWorld rallies again on elevated calls buying</a></h4><ul><li>The bouncy trading on SeaWorld Entertainment (<a href='https://seekingalpha.com/symbol/SEAS' title='SeaWorld Entertainment Inc.'>SEAS</a> <font color='green'>+4.1%</font>) continues.</li><li>Options traders are busy once again with SeaWorld. Bloomberg reports that call activity is almost 3X normal activity as bets on potential SeaWorld M&amp;A continue to be played out.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3298744-options-activity-seaworld-entertainment-picks\" target=\"_blank\">Options activity on SeaWorld Entertainment picks up</a> (Oct. 2)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3299406-seaworld-jumps-7-percent-report-buyer-interest\" target=\"_blank\">Seaworld jumps 7% on report of buyer interest</a> (Oct. 4)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3299480-seaworld-entertainment-spotlight\" target=\"_blank\">SeaWorld Entertainment in the spotlight</a> (Oct. 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3299559-nuggets-potential-seaworld-buyout-deal\" target=\"_blank\">Nuggets on a potential SeaWorld buyout deal</a> (Oct. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3300001\" data-linked=\"SeaWorld rallies again on elevated calls buying\" data-tweet=\"$SEAS - SeaWorld rallies again on elevated calls buying https://seekingalpha.com/news/3300001-seaworld-rallies-again-on-elevated-calls-buying?source=tweet\" data-url=\"https://seekingalpha.com/news/3300001-seaworld-rallies-again-on-elevated-calls-buying\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299999\" data-ts=\"1507565712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZNGA\" target=\"_blank\">ZNGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299999-videogame-shares-slide-cowen-heads-to-sidelines-after-hot-run\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Videogame shares slide as Cowen heads to sidelines after hot run</a></h4><ul>   <li>Videogame stocks are lower today after Cowen goes Neutral across the board, seeing unrealistic 2018 expectations priced into shares.</li>    <li>The firm cut Activision Blizzard (<a href=\"http://seekingalpha.com/symbol/ATVI\" target=\"_blank\">ATVI</a> <font color='red'>-3%</font>), Take-Two Interactive (<a href=\"http://seekingalpha.com/symbol/TTWO\" target=\"_blank\">TTWO</a> <font color='red'>-3.8%</font>) and Ubisoft (<a href=\"http://seekingalpha.com/symbol/UBSFY\" target=\"_blank\">UBSFY</a> <font color='green'>+1.1%</font>) to Market Perform, and reiterated its Neutral stance on Electronic Arts (<a href=\"http://seekingalpha.com/symbol/EA\" target=\"_blank\">EA</a> <font color='red'>-1.2%</font>).</li>    <li>Shares have been on a strong run in 2017 -- year-to-date, ATVI is <font color='green'>up 70%</font>, TTWO <font color='green'>up 109.4%</font>, UBSFY <font color='green'>up 104%</font>, EA <font color='green'>+50.6%</font> -- and Cowen notes that the Street seems to be pricing in 12-13% industry growth, \"well above anything achieved in the last decade.\"</li>    <li>Competition will be higher next year as well, with a packed slate of games vying for limited gamer attention.</li>    <li>While it's still a believer in long-term attractiveness of the sector, there will be at least a 15-20% multiple compression as buy-side expectations dampen, Cowen says.</li>    <li>Also moving: Zynga (NASDAQ:<a href='https://seekingalpha.com/symbol/ZNGA' title='Zynga'>ZNGA</a>), <font color='red'>down 1.9%</font>; Glu Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/GLUU' title='Glu Mobile Inc.'>GLUU</a>), <font color='red'>down 2.7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3299999\" data-linked=\"Videogame shares slide as Cowen heads to sidelines after hot run\" data-tweet=\"$ZNGA $ZNGA $GLUU - Videogame shares slide as Cowen heads to sidelines after hot run https://seekingalpha.com/news/3299999-videogame-shares-slide-cowen-heads-to-sidelines-after-hot-run?source=tweet\" data-url=\"https://seekingalpha.com/news/3299999-videogame-shares-slide-cowen-heads-to-sidelines-after-hot-run\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299994\" data-ts=\"1507564851\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299994-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SORL' title='SORL Auto Parts, Inc.'>SORL</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems, Inc.'>WPRT</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/NC' title='NACCO Industries Inc.'>NC</a> <font color='green'>+5%</font>. <a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Techn'>SGOC</a> <font color='green'>+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3299994\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$SORL $WPRT $FTFT - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3299994-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3299994-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299992\" data-ts=\"1507564696\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CONN\" target=\"_blank\">CONN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299992-conns-peels-back-after-stifel-caution\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Conn&#39;s peels back after Stifel caution</a></h4><ul>     <li>Stifel Nicolaus lowers Conn's (<a href='https://seekingalpha.com/symbol/CONN' title='Conn&#39;s, Inc.'>CONN</a> <font color='red'>-5.9%</font>) to a Hold rating after having the retailer lined up at Buy.</li>     <li>Though analyst John Baugh expresses some concerns on valuation due to the expected impact of Hurricane Harvey on short-term results, the longer view on Conn's is still positive.</li>     <li>\"We have not changed our view that Conn&rsquo;s can be a much higher stock over the next 24-36 months but do see a more difficult path,\" he writes.</li><li>Shares of Conn's are up 128% over the last six months.</li><li>Sources: Bloomberg, Nasdaq.com</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3299992\" data-linked=\"Conn&#39;s peels back after Stifel caution\" data-tweet=\"$CONN - Conn&#39;s peels back after Stifel caution https://seekingalpha.com/news/3299992-conns-peels-back-after-stifel-caution?source=tweet\" data-url=\"https://seekingalpha.com/news/3299992-conns-peels-back-after-stifel-caution\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299991\" data-ts=\"1507564538\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNPR\" target=\"_blank\">JNPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299991-juniper-networks-drops-after-morgan-stanley-note\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Juniper Networks drops after Morgan Stanley note</a></h4><ul><li>        Juniper Networks (NYSE:<a href='https://seekingalpha.com/symbol/JNPR' title='Juniper Networks'>JNPR</a>) shares&nbsp;<font color='red'>drop 3.38%&nbsp;</font>after a Morgan Stanley analyst note citing company headwinds.</li><li>               Analyst James Faucette cites the deceleration of QFX series switches as the cause behind router and security headwinds. Sales have slowed as more customers turn to internal solutions or updated architectures.&nbsp;</li><li>               The firm had already lowered 2018 estimates believing that a transition in product cycle will slow data center switching growth.</li><li>               Morgan Stanley maintains an Underweight rating and a $20 price target.&nbsp;</li><li>               Source: Bloomberg First Word&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3299991\" data-linked=\"Juniper Networks drops after Morgan Stanley note\" data-tweet=\"$JNPR - Juniper Networks drops after Morgan Stanley note https://seekingalpha.com/news/3299991-juniper-networks-drops-after-morgan-stanley-note?source=tweet\" data-url=\"https://seekingalpha.com/news/3299991-juniper-networks-drops-after-morgan-stanley-note\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299990\" data-ts=\"1507564307\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EZPW\" target=\"_blank\">EZPW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299990-ezcorp-up-nearly-5-after-big-latam-purchase\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EZCORP up nearly 5% after big LatAm purchase</a></h4><ul><li>EZCORP (<a href='https://seekingalpha.com/symbol/EZPW' title='EZCORP, Inc.'>EZPW</a> <font color='green'>+4.5%</font>) this morning announced the purchase of GuatePrenda - MaxiEfectivo - an owner and operator of 112 pawn stores in Guatemala (72 stores), El Salvador (17), Honduras (12), and Peru (11).</li><li>This brings the company's store total to 871, including 358 in Latin America.</li><li>Terms: $53.4M in cash at closing, with another $2.25M contingent upon business performance. GPMX had $6.6M of debt that's to be repaid as soon as possible.</li><li>The deal will be immediately accretive to earnings, says EZPW CEO Stuart Grimshaw.</li><li>Source: <a href=\"https://seekingalpha.com/pr/16962494-ezcorp-announces-strategic-acquisition-112-pawn-stores-latin-america\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3299990\" data-linked=\"EZCORP up nearly 5% after big LatAm purchase\" data-tweet=\"$EZPW - EZCORP up nearly 5% after big LatAm purchase https://seekingalpha.com/news/3299990-ezcorp-up-nearly-5-after-big-latam-purchase?source=tweet\" data-url=\"https://seekingalpha.com/news/3299990-ezcorp-up-nearly-5-after-big-latam-purchase\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:51 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299988\" data-ts=\"1507562910\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YUMC\" target=\"_blank\">YUMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299988-nomura-starts-off-bullish-view-on-yum-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nomura starts off with bullish view on Yum China</a></h4><ul><li>Shares of Yum China (<a href='https://seekingalpha.com/symbol/YUMC' title='Yum China'>YUMC</a> <font color='green'>+6%</font>) rally after Nomura Instinet launches coverage with a Buy rating and $51.60 price target on the restaurant stock.</li><li>The PT from the Japanese firm reps 19% upside.</li><li>Yum China reported earnings last week.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3299651-yum-china-misses-0_04-beats-revenue\" target=\"_blank\">Yum China misses by $0.04, beats on revenue</a> (Oct. 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3299666-yum-china-plus-3_5-percent-establishing-dividend-planning-wat-new-ceo\" target=\"_blank\">Yum China +3.5% on establishing dividend, planning for Wat as new CEO</a> (Oct. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3299988\" data-linked=\"Nomura starts off with bullish view on Yum China\" data-tweet=\"$YUMC - Nomura starts off with bullish view on Yum China https://seekingalpha.com/news/3299988-nomura-starts-off-bullish-view-on-yum-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3299988-nomura-starts-off-bullish-view-on-yum-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299987\" data-ts=\"1507562908\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HIIQ\" target=\"_blank\">HIIQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299987-canaccord-bullish-on-health-insurance-innovations-on-planned-trump-exec-order-rolling-back\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canaccord bullish on Health Insurance Innovations on planned Trump exec order rolling back health insurance regs; shares ahead 9%</a></h4><ul><li>Health Insurance Innovations (<a href='https://seekingalpha.com/symbol/HIIQ' title='Health Insurance Innovations'>HIIQ</a> <font color='green'>+8.6%</font>) perks up on light volume on the heels of a note by Canaccord Genuity saying President Trump's expected executive order deregulating Obamacare, including allowing people to buy short-term insurance, should be bullish for the company, a scenario that it says is the main value driver of the stock price (until bearish reports appeared) (BUY/$39).</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3299933-trumps-executive-order-divide-healthcare-market-wsj\" target=\"_blank\">Trump's executive order could divide healthcare market - WSJ</a> (Oct. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3299987\" data-linked=\"Canaccord bullish on Health Insurance Innovations on planned Trump exec order rolling back health insurance regs; shares ahead 9%\" data-tweet=\"$HIIQ - Canaccord bullish on Health Insurance Innovations on planned Trump exec order rolling back health insurance regs; shares ahead 9% https://seekingalpha.com/news/3299987-canaccord-bullish-on-health-insurance-innovations-on-planned-trump-exec-order-rolling-back?source=tweet\" data-url=\"https://seekingalpha.com/news/3299987-canaccord-bullish-on-health-insurance-innovations-on-planned-trump-exec-order-rolling-back\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299986\" data-ts=\"1507562499\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TYPE\" target=\"_blank\">TYPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299986-blr-partners-discloses-active-stake-in-monotype-imaging-holdings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BLR Partners discloses active stake in Monotype Imaging Holdings</a></h4><ul><li>        BLR Partners discloses a 2.3% active stake in Monotype Imaging Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/TYPE' title='Monotype Imaging Holdings Inc.'>TYPE</a>) in a <a href=\"https://www.sec.gov/Archives/edgar/data/1385292/000092189517002384/sc13d06297224_10062017.htm\" target=\"_blank\">regulatory filing</a>.</li><li>                  Monotype Imaging Holdings shares are&nbsp;up 7.21%.   &nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3299986\" data-linked=\"BLR Partners discloses active stake in Monotype Imaging Holdings\" data-tweet=\"$TYPE - BLR Partners discloses active stake in Monotype Imaging Holdings https://seekingalpha.com/news/3299986-blr-partners-discloses-active-stake-in-monotype-imaging-holdings?source=tweet\" data-url=\"https://seekingalpha.com/news/3299986-blr-partners-discloses-active-stake-in-monotype-imaging-holdings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299983\" data-ts=\"1507562310\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSPM\" target=\"_blank\">BSPM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299983-biostar-up-42-news-scarce\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biostar up 42% but news scarce</a></h4><ul><li>Thinly traded nano cap <a href=\"http://www.biostarpharmaceuticals.com/\" target=\"_blank\">Biostar Pharmaceuticals</a> (<a href='https://seekingalpha.com/symbol/BSPM' title='Biostar Pharmaceutic'>OTC:BSPM</a> <font color='green'>+42.1%</font>) jumps in early trading on a massive 45x surge in volume. No particular news accounts for the action.</li><li>Last month, the company notified the SEC that it would be late filing its Q2 financials.</li><li>The Xiangyang, China-based firm sells its products in-country. Its top seller is Xin Ao Xing Oleanolic Acid Capsules for the treatment of hepatitis B.</li><li>Partner Aoxing Pharmaceuticals shut down production in May for maintenance but was supposed to restart its lines in Q3.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3268888-biostar-books-sales-q1-aoxing-shuts-production-lines\" target=\"_blank\">Biostar books no sales in Q1 as Aoxing shuts down production lines</a> (May 19)</li></ul><div class=\"tiny-share-widget\" data-id=\"3299983\" data-linked=\"Biostar up 42% but news scarce\" data-tweet=\"$BSPM - Biostar up 42% but news scarce https://seekingalpha.com/news/3299983-biostar-up-42-news-scarce?source=tweet\" data-url=\"https://seekingalpha.com/news/3299983-biostar-up-42-news-scarce\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299984\" data-ts=\"1507562247\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TA\" target=\"_blank\">TA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299984-travelcenters-of-america-peels-off-7\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TravelCenters of America peels off 7%</a></h4><ul><li>Shares of TravelCenters of America (NYSEMKT:<a href='https://seekingalpha.com/symbol/TA' title='TravelCenters of America LLC'>TA</a>) are&nbsp;<font color='red'>down 7%</font>&nbsp;as investors reassess valuation after last week's 27% rally.</li><li>TravelCenters fell on the M&amp;A radar of some traders when Berkshire Hathaway snapped up a sizable stake in Pilot Travel Centers.</li></ul><div class=\"tiny-share-widget\" data-id=\"3299984\" data-linked=\"TravelCenters of America peels off 7%\" data-tweet=\"$TA - TravelCenters of America peels off 7% https://seekingalpha.com/news/3299984-travelcenters-of-america-peels-off-7?source=tweet\" data-url=\"https://seekingalpha.com/news/3299984-travelcenters-of-america-peels-off-7\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299980\" data-ts=\"1507561780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIA\" target=\"_blank\">VIA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299980-viacom-tumbles-citi-cuts-to-sell-on-carriage-risks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viacom tumbles as Citi cuts to Sell on carriage risks</a></h4><ul>   <li>Viacom shares (<a href='https://seekingalpha.com/symbol/VIA' title='Viacom Inc.'>VIA</a> <font color='red'>-3.5%</font>, <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> <font color='red'>-5.7%</font>) have slid after a cut to Sell at Citigroup, which points to channel carriage issues as the key headwind.</li>    <li>The company faces \"acute\" risk that Charter (NASDAQ:<a href='https://seekingalpha.com/symbol/CHTR' title='Charter Communications, Inc.'>CHTR</a>) is going to drop or at least \"significantly curtail\" its distribution of Viacom content, analyst Jason Bazinet says.</li>    <li>Viacom's salad days are over, Bazinet says, noting that it can no longer count on auto-renewals of fat content bundles with affiliate fee step-ups.</li>    <li>Viacom's faced years of ratings challenges at its key networks: MTV/VH1, Comedy Central, Nickelodeon and BET.</li>    <li>Looking at renewal scenarios, Bazinet trims Citi's price target on <a href='https://seekingalpha.com/symbol/VIAB' title='Viacom Inc.'>VIAB</a> to $24 from $33; that implies 6.3% downside from today's sharply lower price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3299980\" data-linked=\"Viacom tumbles as Citi cuts to Sell on carriage risks\" data-tweet=\"$VIA $VIA $VIAB - Viacom tumbles as Citi cuts to Sell on carriage risks https://seekingalpha.com/news/3299980-viacom-tumbles-citi-cuts-to-sell-on-carriage-risks?source=tweet\" data-url=\"https://seekingalpha.com/news/3299980-viacom-tumbles-citi-cuts-to-sell-on-carriage-risks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299960\" data-ts=\"1507561245\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299960-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/BSPM' title='Biostar Pharmaceutic'>OTC:BSPM</a> <font color='green'>+45%</font>. <a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/ALT' title='Altimmune, Inc.'>ALT</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/ATEC' title='Alphatec Holdings, Inc.'>ATEC</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/KTWO' title='K2M Group Holdings, Inc.'>KTWO</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/XXII' title='22nd Century Group, Inc.'>XXII</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/NVIV' title='InVivo Therapeutics Holdings Corp'>NVIV</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MRNS' title='Marinus Pharmaceuticals'>MRNS</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3299960\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$BSPM $ONTX $ALT - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3299960-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3299960-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299977\" data-ts=\"1507561134\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KTWO\" target=\"_blank\">KTWO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299977-k2m-sees-6-revenue-growth-in-q3-lowers-2017-guidance-shares-down-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">K2M sees 6% revenue growth in Q3, lowers 2017 guidance; shares down 18%</a></h4><ul><li>K2M Group Holdings (<a href='https://seekingalpha.com/symbol/KTWO' title='K2M Group Holdings, Inc.'>KTWO</a> <font color='red'>-18%</font>) slumps on almost 5x higher volume on the heels of its <a href=\"https://seekingalpha.com/pr/16962496-k2m-group-holdings-inc-reports-preliminary-third-quarter-revenue-results-updates-full-year\" target=\"_blank\">announcement </a>of preliminary Q3 numbers. Sales should be ~$62.7M, up 6% yoy but down from Q2's 11% growth.</li><li>CEO Eric Major says, &ldquo;Our preliminary third quarter revenue performance was driven by slower than planned acceleration of new distribution in the&nbsp;U.S., disruption of account activity and canceled procedures related to the hurricanes in&nbsp;Texas,&nbsp;Florida and, to a lesser extent,&nbsp;Puerto Rico, in early September. Third quarter deformity trends were strong in July and August and we experienced strong headwinds in September.&nbsp;U.S.&nbsp;sales growth in our degenerative procedure category continued to be fueled by our new product introductions including our industry-leading 3D-printed portfolio, offset partially by modestly weaker procedure volumes as compared to last year.&rdquo;</li><li><strong>2017 revenue guidance</strong> has been revised downward: total revenue: $255M - 257M from $263M - 270M, revenue growth (constant currency): 8 - 9% from 12 - 15%; U.S. business growth: 8 - 9% from mid-teens. International business growth revised upward: 9% from mid-single-digit.</li></ul><div class=\"tiny-share-widget\" data-id=\"3299977\" data-linked=\"K2M sees 6% revenue growth in Q3, lowers 2017 guidance; shares down 18%\" data-tweet=\"$KTWO - K2M sees 6% revenue growth in Q3, lowers 2017 guidance; shares down 18% https://seekingalpha.com/news/3299977-k2m-sees-6-revenue-growth-in-q3-lowers-2017-guidance-shares-down-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3299977-k2m-sees-6-revenue-growth-in-q3-lowers-2017-guidance-shares-down-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299978\" data-ts=\"1507560896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMC\" target=\"_blank\">AMC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299978-theater-stocks-retreat-after-blade-runner-debut-falls-short\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Theater stocks retreat after Blade Runner debut falls short</a></h4><ul><li>Theater stocks give back some of the gains built up last week after <em>Blade Runner 2049</em> missed box office estimates with its weekend run.</li><li>AMC Entertainment (<a href='https://seekingalpha.com/symbol/AMC' title='AMC Entertainment Holdings, Inc'>AMC</a> <font color='red'>-5.8%</font>), IMAX (<a href='https://seekingalpha.com/symbol/IMAX' title='IMAX Corporation'>IMAX</a> <font color='red'>-2.4%</font>), Cinemark Holdings (<a href='https://seekingalpha.com/symbol/CNK' title='Cinemark Holdings, Inc'>CNK</a> <font color='red'>-2.8%</font>), Regal Entertainment (<a href='https://seekingalpha.com/symbol/RGC' title='Regal Entertainment Group'>RGC</a> <font color='red'>-4.9%</font>) and National CineMedia (<a href='https://seekingalpha.com/symbol/NCMI' title='National CineMedia, Inc.'>NCMI</a> <font color='red'>-4.1%</font>) are all notably lower.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3299883-blade-runner-sequel-leads-box-office-falls-short-estimates\" target=\"_blank\">Blade Runner sequel leads box office, falls short of estimates</a> (Oct. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3299978\" data-linked=\"Theater stocks retreat after Blade Runner debut falls short\" data-tweet=\"$AMC $AMC $IMAX - Theater stocks retreat after Blade Runner debut falls short https://seekingalpha.com/news/3299978-theater-stocks-retreat-after-blade-runner-debut-falls-short?source=tweet\" data-url=\"https://seekingalpha.com/news/3299978-theater-stocks-retreat-after-blade-runner-debut-falls-short\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299976\" data-ts=\"1507560730\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/X\" target=\"_blank\">X</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299976-rough-session-for-steelmakers-after-big-drop-in-scrap-prices\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rough session for steelmakers after big drop in scrap prices</a></h4><ul><li>via Bloomberg</li><li>\"It's the scrap settlement that was finalized with obsolete down $30/ton and prime down $40/ton,\" says Credit Suisse's Curt Woodworth, noting weak export demand.</li><li>U.S. Steel (<a href='https://seekingalpha.com/symbol/X' title='United States Steel Corporation'>X</a> <font color='red'>-4.6%</font>), AK Steel (<a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='red'>-4%</font>), Nucor (<a href='https://seekingalpha.com/symbol/NUE' title='Nucor Corporation'>NUE</a> <font color='red'>-1.1%</font>), Timkensteel (<a href='https://seekingalpha.com/symbol/TMST' title='TimkenSteel Corp.'>TMST</a> <font color='red'>-2.4%</font>), Steel Dynamics (<a href='https://seekingalpha.com/symbol/STLD' title='Steel Dynamics, Inc.'>STLD</a> <font color='red'>-1%</font>), ArcelorMittal (<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='red'>-1.1%</font>).</li></ul><div class=\"tiny-share-widget\" data-id=\"3299976\" data-linked=\"Rough session for steelmakers after big drop in scrap prices\" data-tweet=\"$X $X $AKS - Rough session for steelmakers after big drop in scrap prices https://seekingalpha.com/news/3299976-rough-session-for-steelmakers-after-big-drop-in-scrap-prices?source=tweet\" data-url=\"https://seekingalpha.com/news/3299976-rough-session-for-steelmakers-after-big-drop-in-scrap-prices\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299972\" data-ts=\"1507559730\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONTX\" target=\"_blank\">ONTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299972-onconova-up-18-on-positive-phase-3-outlook-on-lead-candidate-rigosertib\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Onconova up 18% on positive Phase 3 outlook on lead candidate rigosertib</a></h4><ul><li>Thinly traded nano cap Onconova Therapeutics (<a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a> <font color='green'>+17.7%</font>) is up on a 5x surge in volume on the heels of a bullish call from H.C. Wainwright (BUY/$6) citing positive expectations from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT02562443?term=rigosertib&amp;phase=2&amp;rank=3\" target=\"_blank\">Phase 3 clinical trial</a> assessing lead candidate rigosertib in higher-risk myelodysplastic syndrome &#40;MDS&#41; patients. Topline data should be available by late H1 2018.</li><li>Rigosertib is a small molecule that inhibits cellular signaling by acting as a&nbsp;<a href=\"https://en.wikipedia.org/wiki/Ras_subfamily\" target=\"_blank\">Ras protein</a>&nbsp;mimetic. Ras is a family of proteins that are involved in transmitting signals within cells. When switched \"on\", it activates other proteins that ultimately turn on genes involved in cell growth, differentiation and survival.</li><li>On Wednesday, October 11, the company will host a Key Opinion Leader <a href=\"https://seekingalpha.com/pr/16959237-onconova-host-key-opinion-leader-meeting-novel-approaches-diagnosis-treatment-pediatric\" target=\"_blank\">meeting </a>focused on the diagnosis and treatment of RASopathies.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3210802-onconova-completes-end-phase-2-meeting-fda-regarding-lead-product-candidate-rigosertib\" target=\"_blank\">Onconova completes end-of-Phase 2 meeting with FDA regarding lead product candidate rigosertib; informs on Phase 3 design</a> (Sept. 26, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3299972\" data-linked=\"Onconova up 18% on positive Phase 3 outlook on lead candidate rigosertib\" data-tweet=\"$ONTX - Onconova up 18% on positive Phase 3 outlook on lead candidate rigosertib https://seekingalpha.com/news/3299972-onconova-up-18-on-positive-phase-3-outlook-on-lead-candidate-rigosertib?source=tweet\" data-url=\"https://seekingalpha.com/news/3299972-onconova-up-18-on-positive-phase-3-outlook-on-lead-candidate-rigosertib\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299971\" data-ts=\"1507559464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMF\" target=\"_blank\">OMF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299971-onemain-financial-up-nearly-12-on-report-of-sale-talks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OneMain Financial up nearly 12% on report of sale talks</a></h4><ul><li><a href=\"https://www.wsj.com/articles/onemain-citigroups-former-subprime-lender-fields-takeover-bids-1507485126\" target=\"_blank\">According to a weekend <em>WSJ</em> report</a>, OneMain Financial (<a href='https://seekingalpha.com/symbol/OMF' title='OneMain Holdings, Inc.'>OMF</a> <font color='green'>+11.7%</font>) is in advanced discussions with a number of possible buyers - both other lenders and P-E shops.</li><li>The subprime lender has turned around a rough run, now up nearly 50% this year after cutting debt and pivoting to more lending backed by collateral, rather than unsecured loans.</li><li>It's 55% owned by Fortress Investment Group (NYSE:<a href='https://seekingalpha.com/symbol/FIG' title='Fortress Investment Group LLC'>FIG</a>), which is in the process of being sold to SoftBank Group.</li></ul><div class=\"tiny-share-widget\" data-id=\"3299971\" data-linked=\"OneMain Financial up nearly 12% on report of sale talks\" data-tweet=\"$OMF $OMF $FIG - OneMain Financial up nearly 12% on report of sale talks https://seekingalpha.com/news/3299971-onemain-financial-up-nearly-12-on-report-of-sale-talks?source=tweet\" data-url=\"https://seekingalpha.com/news/3299971-onemain-financial-up-nearly-12-on-report-of-sale-talks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299969\" data-ts=\"1507559443\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZEN\" target=\"_blank\">ZEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299969-stephens-downgrades-zendesk\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stephens downgrades Zendesk</a></h4><ul><li>        Stephens <a href=\"https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=newssearch&amp;cd=1&amp;cad=rja&amp;uact=8&amp;ved=0ahUKEwiUicvg3-PWAhWMKyYKHdSZB6IQqQIIJSgAMAA&amp;url=https%3A%2F%2Fwww.streetinsider.com%2FAnalyst%2BComments%2FStephens%2BDowngrades%2BZendesk%2B%28ZEN%29%2Bto%2BUnderweight%2F13371569.html&amp;usg=AOvVaw2qeczMKVHjgJi6CpvpB5pt\" target=\"_blank\">downgrades</a> Zendesk (NYSE:<a href='https://seekingalpha.com/symbol/ZEN' title='Zendesk, Inc.'>ZEN</a>) from Equal Weight to Underweight with a $25 price target.</li><li>                  Latest analyst standings on Zendesk: 6 Buy, 12 Outperform, and 2 Hold.    </li><li>               Median price target: $33.&nbsp;</li><li>                  Zendesk shares are&nbsp;<font color='red'>down 3.31%</font>&nbsp;to $30.08.    &nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3299969\" data-linked=\"Stephens downgrades Zendesk\" data-tweet=\"$ZEN - Stephens downgrades Zendesk https://seekingalpha.com/news/3299969-stephens-downgrades-zendesk?source=tweet\" data-url=\"https://seekingalpha.com/news/3299969-stephens-downgrades-zendesk\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299966\" data-ts=\"1507558972\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MLNX\" target=\"_blank\">MLNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299966-barclays-downgrades-mellanox\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barclays downgrades Mellanox</a></h4><ul><li>           Barclays <a href=\"https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=newssearch&amp;cd=1&amp;cad=rja&amp;uact=8&amp;ved=0ahUKEwjf8s_H3ePWAhXK5SYKHb-tDaEQqQIIJCgAMAA&amp;url=https%3A%2F%2Fwww.streetinsider.com%2FAnalyst%2BComments%2FBarclays%2BDowngrades%2BMellanox%2BTechnologies%2B%28MLNX%29%2Bto%2BUnderweight%2BCiting%2BLimited%2BUpside%2BPotential%2F13371376.html&amp;usg=AOvVaw3cTuozCT340pe2XE-TzYMn\" target=\"_blank\">downgrades</a> Mellanox Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/MLNX' title='Mellanox Technologies, Ltd.'>MLNX</a>) from Equal Weight to Underweight and lowers the price target by $2 to $48. </li><li> Latest analyst standings on Mellanox: 3 Buy, 3 Outperform, 9 Hold, and 1 Sell. </li><li> Median price target: $60. </li><li> Mellanox shares are&nbsp;<font color='red'>down 3.79%</font>&nbsp;to $45.70.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3299966\" data-linked=\"Barclays downgrades Mellanox\" data-tweet=\"$MLNX - Barclays downgrades Mellanox https://seekingalpha.com/news/3299966-barclays-downgrades-mellanox?source=tweet\" data-url=\"https://seekingalpha.com/news/3299966-barclays-downgrades-mellanox\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299965\" data-ts=\"1507558590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALT\" target=\"_blank\">ALT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299965-altimmune-up-19-on-piper-upgrade-data-from-phase-2-nasovax-study-expected-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altimmune up 19% on Piper upgrade, data from Phase 2 NasoVAX study expected in Q1</a></h4><ul><li>Thinly traded nano cap Altimmune (<a href='https://seekingalpha.com/symbol/ALT' title='Altimmune, Inc.'>ALT</a> <font color='green'>+18.9%</font>) is up on triple normal volume, albeit on turnover of only ~150K shares, on the heels of an upgrade to Overweight with a $6 (122% upside) price target by Piper Jaffray.</li><li><a href=\"https://seekingalpha.com/pr/16945930-altimmune-announces-phase-2-flu-vaccine-trial-nasovax-open-enrollment\" target=\"_blank\">Topline data</a> from a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03232567\" target=\"_blank\">Phase 2 study</a> of recombinant nasal spray flu vaccine NasoVAX should be released in Q1 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3299965\" data-linked=\"Altimmune up 19% on Piper upgrade, data from Phase 2 NasoVAX study expected in Q1\" data-tweet=\"$ALT - Altimmune up 19% on Piper upgrade, data from Phase 2 NasoVAX study expected in Q1 https://seekingalpha.com/news/3299965-altimmune-up-19-on-piper-upgrade-data-from-phase-2-nasovax-study-expected-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3299965-altimmune-up-19-on-piper-upgrade-data-from-phase-2-nasovax-study-expected-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299959\" data-ts=\"1507557502\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GE\" target=\"_blank\">GE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299959-general-electric-down-3-after-management-shake-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">General Electric down 3% after management shake-up</a></h4><ul><li>Alongside the exit of the CFO and three vice chairs <a href=\"https://seekingalpha.com/news/3299847-ge-names-new-chief-financial-officer-three-vice-chairs-exiting-company\" target=\"_blank\">announced after the close</a> on Friday, General Electric (<a href='https://seekingalpha.com/symbol/GE' title='General Electric'>GE</a> <font color='red'>-3%</font>) this morning <a href=\"https://seekingalpha.com/pr/16962439-ge-elects-ed-garden-trian-partners-board-directors\" target=\"_blank\">announced Trian Fund founding partner</a> Ed Garden as moving onto the board, replacing Robert Lane, who is retiring for health reasons.</li><li>Trian is an owner of about 1% of GE.</li><li>Garden: \"I am disappointed by the recent performance of GE's stock. But I continue to believe that GE represents an attractive long-term investment opportunity with significant upside.\"</li><li>No details beyond the headline, but JPMorgan is calling the executive departures a \"clear negative\" for the company.</li></ul><div class=\"tiny-share-widget\" data-id=\"3299959\" data-linked=\"General Electric down 3% after management shake-up\" data-tweet=\"$GE - General Electric down 3% after management shake-up https://seekingalpha.com/news/3299959-general-electric-down-3-after-management-shake-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3299959-general-electric-down-3-after-management-shake-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>67&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299958\" data-ts=\"1507556935\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TUR\" target=\"_blank\">TUR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299958-turkey-tumbles-on-diplomatic-row-u-s\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Turkey tumbles on diplomatic row with U.S.</a></h4><ul><li>The U.S. over the weekend <a href=\"https://www.reuters.com/article/us-usa-turkey-security/turkey-urges-u-s-to-review-visa-suspension-as-lira-stocks-tumble-idUSKBN1CD0SC\" target=\"_blank\">suspended non-immigrant visa services</a> for travel from Turkey, effectively blocking Turks from travel to the U.S. Turkey retaliated with similar action (this one blocking Americans from traveling to Turkey).</li><li>The row began after Turkey's arrest last week of a Turkish employee of the U.S. consulate in Istanbul.</li><li>Turkish stocks and the lira are both sharply lower. The iShares MSCI Turkey ETF (NASDAQ:<a href='https://seekingalpha.com/symbol/TUR' title='iShares MSCI Turkey ETF'>TUR</a>) is&nbsp;<font color='red'>down 5.8%</font>&nbsp;in early action.</li></ul><div class=\"tiny-share-widget\" data-id=\"3299958\" data-linked=\"Turkey tumbles on diplomatic row with U.S.\" data-tweet=\"$TUR - Turkey tumbles on diplomatic row with U.S. https://seekingalpha.com/news/3299958-turkey-tumbles-on-diplomatic-row-u-s?source=tweet\" data-url=\"https://seekingalpha.com/news/3299958-turkey-tumbles-on-diplomatic-row-u-s\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299951\" data-ts=\"1507555120\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299951-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li>CLNT <font color='green'>+39%</font>&nbsp;on exclusivity <a href=\"https://seekingalpha.com/pr/16962415-inseego-undagrid-announce-global-strategic-partnership\" target=\"_blank\">agreement</a> to acquire&nbsp;Inspirit Studio.</li>     <li><a href='https://seekingalpha.com/symbol/INSG' title='Inseego Corp.'>INSG</a> <font color='green'>+18%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/pr/16962415-inseego-undagrid-announce-global-strategic-partnership\" target=\"_blank\">announcing</a>&nbsp;global strategic partnership with&nbsp;Undagrid.</li>     <li><a href='https://seekingalpha.com/symbol/CGEN' title='Compugen Ltd.'>CGEN</a> <font color='green'>+13%</font>&nbsp;as CGEN-15032 <a href=\"https://seekingalpha.com/news/3299913\" target=\"_blank\">shows</a> potential as immuno-suppressive target in research study.</li>     <li><a href='https://seekingalpha.com/symbol/TTNP' title='Titan Pharmaceuticals, Inc.'>TTNP</a> <font color='green'>+8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/MZOR' title='Mazor Robotics Ltd.'>MZOR</a> <font color='green'>+8%</font>&nbsp;on the <a href=\"https://seekingalpha.com/pr/16962391-mazor-robotics-received-22-system-orders-q3-2017-expects-report-record-quarterly-revenue\" target=\"_blank\">guidance</a> of record quarterly revenue and 22 system orders.</li>     <li><a href='https://seekingalpha.com/symbol/BLDP' title='Ballard Power Systems, Inc.'>BLDP</a> <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CDNA' title='CareDx'>CDNA</a> <font color='green'>+7%</font>&nbsp;on positive <a href=\"https://seekingalpha.com/news/3299900-premarket-analyst-action-healthcare\" target=\"_blank\">analyst action</a>.</li>     <li><a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a> <font color='green'>+7%</font>&nbsp;on positive&nbsp;<a href=\"https://seekingalpha.com/news/3299900-premarket-analyst-action-healthcare\" target=\"_blank\">analyst action</a>.</li>     <li><a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a> <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/TXMD' title='TherapeuticsMD'>TXMD</a> <font color='green'>+6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3299951\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$SEII $INSG $CGEN - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3299951-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3299951-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299950\" data-ts=\"1507555110\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNDM\" target=\"_blank\">TNDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299950-tandem-diabetes-to-reverse-split-shares-1-10-after-close-shares-off-4-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tandem Diabetes to reverse split shares 1:10 after the close; shares off 4% premarket</a></h4><ul><li>Tandem Diabetes Care (NASDAQ:<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a>) will execute a <a href=\"https://seekingalpha.com/pr/16962729-tandem-diabetes-care-announces-approval-reverse-stock-split\" target=\"_blank\">1:10 reverse split</a> of its common shares at 4:00 pm ET today. Post-split trading will commence tomorrow, October 10, at the open.</li><li>Shares are down&nbsp;<font color='red'>4%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3299950\" data-linked=\"Tandem Diabetes to reverse split shares 1:10 after the close; shares off 4% premarket\" data-tweet=\"$TNDM - Tandem Diabetes to reverse split shares 1:10 after the close; shares off 4% premarket https://seekingalpha.com/news/3299950-tandem-diabetes-to-reverse-split-shares-1-10-after-close-shares-off-4-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3299950-tandem-diabetes-to-reverse-split-shares-1-10-after-close-shares-off-4-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299948\" data-ts=\"1507554897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSG\" target=\"_blank\">INSG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299948-inseegoplus-6_7-on-partnering-tracker-undagrid\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inseego +6.7% on partnering with tracker Undagrid</a></h4><ul>   <li>Inseego (NASDAQ:<a href='https://seekingalpha.com/symbol/INSG' title='Inseego Corp.'>INSG</a>) is <font color='green'>up 6.7%</font> after word of a <a href=\"https://seekingalpha.com/pr/16962415-inseego-undagrid-announce-global-strategic-partnership\" target=\"_blank\">strategic partnership with Undagrid</a> on asset information systems in aviation markets.</li>    <li>Undagrid specializes in non-motorized asset tracking. A combination with Inseego's Ctrack has won a large project at Amsterdam's airport with KLM.</li>    <li>Ctrack has also deployed at airports in Germany and Asia, Inseego says.</li>    <li>The combination offers customers significant reductions on total fleets as well as automated billing.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3299948\" data-linked=\"Inseego +6.7% on partnering with tracker Undagrid\" data-tweet=\"$INSG - Inseego +6.7% on partnering with tracker Undagrid https://seekingalpha.com/news/3299948-inseegoplus-6_7-on-partnering-tracker-undagrid?source=tweet\" data-url=\"https://seekingalpha.com/news/3299948-inseegoplus-6_7-on-partnering-tracker-undagrid\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299943\" data-ts=\"1507554564\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299943-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/XXII' title='22nd Century Group, Inc.'>XXII</a> <font color='red'>-16%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/16962437-22nd-century-group-announces-54-million-common-stock-registered-direct-offering\" target=\"_blank\">announcing</a> $54M common stock only registered direct offering.</li><li><a href='https://seekingalpha.com/symbol/LINU-OLD' title='LiNiu Technology Group'>LINU-OLD</a> <font color='red'>-13%</font>.</li><li><a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a> <font color='red'>-8%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3299943\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$XXII $LINU-OLD $PTCT - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3299943-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3299943-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299927\" data-ts=\"1507552542\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYNA\" target=\"_blank\">SYNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299927-mizuho-downgrades-synaptics-cites-misplaced-optimism-on-tddi\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mizuho downgrades Synaptics, cites misplaced optimism on TDDI</a></h4><ul><li>        Mizuho downgrades Synaptics (NASDAQ:<a href='https://seekingalpha.com/symbol/SYNA' title='Synaptics Incorporated'>SYNA</a>) from Buy to Neutral and lowers the price target to $42 from $66.</li><li>               The firm sees challenges to Synaptics&rsquo; core businesses due to declining LCD and driver IC sales, increasing TDDI competition, and a declining iPhone product mix.&nbsp;</li><li>                  Mizuho calls its previous optimism for the TDDI market &ldquo;misplaced&rdquo; and notes that the Face ID feature in the new iPhone X is an example of rising alternative technologies.    </li><li>               Source: <a href=\"http://www.briefing.com/DisplayArticle/ArticlePopup.aspx?ArticleId=IN20171009061643CALLS\" target=\"_blank\">Briefing.com</a>&nbsp;</li><li>               Synaptics shares are&nbsp;<font color='red'>down 2.08%</font>&nbsp;premarket. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3299927\" data-linked=\"Mizuho downgrades Synaptics, cites misplaced optimism on TDDI\" data-tweet=\"$SYNA - Mizuho downgrades Synaptics, cites misplaced optimism on TDDI https://seekingalpha.com/news/3299927-mizuho-downgrades-synaptics-cites-misplaced-optimism-on-tddi?source=tweet\" data-url=\"https://seekingalpha.com/news/3299927-mizuho-downgrades-synaptics-cites-misplaced-optimism-on-tddi\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299926\" data-ts=\"1507551991\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDXG\" target=\"_blank\">MDXG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299926-mimedx-board-of-directors-authorizes-10m-increase-to-companys-share-repurchase-program-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MiMedx Board of Directors authorizes $10M increase to the company&#39;s Share Repurchase Program; shares ahead 2% premarket</a></h4><ul> <li>MiMedx Group (<a href='https://seekingalpha.com/symbol/MDXG' title='MiMedx Group Inc.'>OTC:MDXG</a>) <a href=\"https://seekingalpha.com/pr/16962517-mimedx-board-directors-authorizes-10-million-increase-companys-share-repurchase-program\" target=\"_blank\">announces</a> the decision of its Board of Directors to authorize a $10M increase in the Company's Share Repurchase Program.</li> <li>This action brings the total authorized to&nbsp;$110M&nbsp;since the Share Repurchase Program commenced in&nbsp;May 2014. The Board also agreed to review this program again on October 26 and to consider an additional commitment at that time.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket on light volume. Yesterday's close was $12.13.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3299926\" data-linked=\"MiMedx Board of Directors authorizes $10M increase to the company&#39;s Share Repurchase Program; shares ahead 2% premarket\" data-tweet=\"$MDXG - MiMedx Board of Directors authorizes $10M increase to the company&#39;s Share Repurchase Program; shares ahead 2% premarket https://seekingalpha.com/news/3299926-mimedx-board-of-directors-authorizes-10m-increase-to-companys-share-repurchase-program-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3299926-mimedx-board-of-directors-authorizes-10m-increase-to-companys-share-repurchase-program-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299913\" data-ts=\"1507550018\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGEN\" target=\"_blank\">CGEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299913-compugens-cgenminus-15032-shows-potential-immuno-suppressive-target-in-research-study-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Compugen&#39;s CGEN-15032 shows potential as immuno-suppressive target in research study, shares ahead 8% premarket</a></h4><ul><li>Thinly traded micro cap Compugen (NASDAQ:<a href='https://seekingalpha.com/symbol/CGEN' title='Compugen Ltd.'>CGEN</a>) is up&nbsp;<font color='green'>8%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/16962478-new-immunomodulatory-target-discovered-compugen-demonstrates-potential-first-class-cancer\" target=\"_blank\">announcement </a>of positive research results related to CGEN-15032, a potential target for immuno-suppressive cancer therapy. The data were presented at the 3rd annual CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference in Mainz/Frankfurt, Germany.</li><li>The research, performed at Johns Hopkins University School of Medicine suggests that CGEN-15032 may serve as an immuno-suppressive target within the tumor microenvironment. In an animal model, CGEN-15032-deficient mice treated with a PD-L1 inhibitor experienced reduced tumor growth compared to wild-type mice treated with an anti-PD-L1 antibody.</li><li>The company has also extended its multiyear immuno-oncology research collaboration with Johns Hopkins to include additional targets.</li></ul><div class=\"tiny-share-widget\" data-id=\"3299913\" data-linked=\"Compugen&#39;s CGEN-15032 shows potential as immuno-suppressive target in research study, shares ahead 8% premarket\" data-tweet=\"$CGEN - Compugen&#39;s CGEN-15032 shows potential as immuno-suppressive target in research study, shares ahead 8% premarket https://seekingalpha.com/news/3299913-compugens-cgenminus-15032-shows-potential-immuno-suppressive-target-in-research-study-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3299913-compugens-cgenminus-15032-shows-potential-immuno-suppressive-target-in-research-study-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:53 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299914\" data-ts=\"1507549689\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ERIC\" target=\"_blank\">ERIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299914-ericsson-announces-new-chairman\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ericsson announces new chairman</a></h4><ul><li>        Ericsson (NASDAQ:<a href='https://seekingalpha.com/symbol/ERIC' title='LM Ericsson Telephone Company'>ERIC</a>) <a href=\"http://in.reuters.com/article/ericsson-chairman/recovery-hopes-rise-as-ericsson-picks-ex-atlas-copco-boss-as-chairman-idINKBN1CE0EW?feedType=RSS&amp;feedName=businessNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FINbusinessNews+%28News+%2F+IN+%2F+Business+News%29\" target=\"_blank\">picks</a> former Atlas Copco boss Ronnie Leten as its new chairman.</li><li>               Leten succeeds Leif Johansson in the chairman position and would come aboard as the company pushes to improve its competitive advantage in the crowded telecom market.&nbsp;</li><li>               Ericsson announced Borje Ekholm as its new CEO earlier this year, but an activist investor pushed for more changes.&nbsp;</li><li>               Leten&rsquo;s hire depends upon a shareholder vote scheduled for March 28. &nbsp;&nbsp;</li><li>Ericsson shares are&nbsp;<font color='green'>up 1.92%</font>&nbsp;premarket.&nbsp; &nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3299914\" data-linked=\"Ericsson announces new chairman\" data-tweet=\"$ERIC - Ericsson announces new chairman https://seekingalpha.com/news/3299914-ericsson-announces-new-chairman?source=tweet\" data-url=\"https://seekingalpha.com/news/3299914-ericsson-announces-new-chairman\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299910\" data-ts=\"1507548789\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MZOR\" target=\"_blank\">MZOR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299910-mazor-robotics-expects-q3-revenue-of-17_2m-shares-ahead-9-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mazor Robotics expects Q3 revenue of $17.2M; shares ahead 9% premarket</a></h4><ul> <li>Mazor Robotics (NASDAQ:<a href='https://seekingalpha.com/symbol/MZOR' title='Mazor Robotics Ltd.'>MZOR</a>) <a href=\"https://seekingalpha.com/pr/16962391-mazor-robotics-received-22-system-orders-q3-2017-expects-report-record-quarterly-revenue\" target=\"_blank\">expects</a> to report record       revenue of ~$17.2M for Q3 ended       September 30. During the quarter, the Company       received a total of 22 system purchase orders from customers in the       U.S., Asia and Israel.</li>     <li>Mazor's system backlog at the end of Q3 was 17 systems. The Company intends to report       its Q3 financial results on       or about November 7.</li><li>Shares are up&nbsp;<font color='green'>9</font>%&nbsp;premarket on light volume.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3299910\" data-linked=\"Mazor Robotics expects Q3 revenue of $17.2M; shares ahead 9% premarket\" data-tweet=\"$MZOR - Mazor Robotics expects Q3 revenue of $17.2M; shares ahead 9% premarket https://seekingalpha.com/news/3299910-mazor-robotics-expects-q3-revenue-of-17_2m-shares-ahead-9-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3299910-mazor-robotics-expects-q3-revenue-of-17_2m-shares-ahead-9-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299900\" data-ts=\"1507548712\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WCG\" target=\"_blank\">WCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299900-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Wellcare (NYSE:<a href='https://seekingalpha.com/symbol/WCG' title='WellCare Health Plans, Inc.'>WCG</a>) initiated with Outperform rating and $200 (15% upside) price target by Cowen and Company.</li><li>Altimmune (NASDAQ:<a href='https://seekingalpha.com/symbol/ALT' title='Altimmune, Inc.'>ALT</a>) initiated with Overweight rating and $6 (164% upside) price target by Piper Jaffray.</li><li>Almost Family (NASDAQ:<a href='https://seekingalpha.com/symbol/AFAM' title='Almost Family Inc'>AFAM</a>) initiated with Neutral rating and $54 (7% upside) price target by JPMorgan.</li><li>Onconova Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ONTX' title='Onconova Therapeutics'>ONTX</a>) initiated with Buy rating and $6 (243% upside) by H.C. Wainwright citing optimism over new Phase 3 study of rigosertib in MDS. Topline data expected in H1 2018.</li><li>Johnson &amp; Johnson (NYSE:<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a>) upgraded to Outperform by Wells Fargo. Shares up&nbsp;<font color='green'>1%</font>&nbsp;premarket.</li><li>MannKind (NASDAQ:<a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a>) price target raised to $7 (32% upside) by Maxim Group. Shares up&nbsp;<font color='green'>4%&nbsp;</font>premarket.</li><li>Juno Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/JUNO' title='Juno Therapeutics'>JUNO</a>) price target raised to $56 (28% upside) by Maxim Group citing bullish prospects for CAR T therapies and JCAR017.</li><li>CareDx (NASDAQ:<a href='https://seekingalpha.com/symbol/CDNA' title='CareDx'>CDNA</a>) price target raised to $10 (78% upside) from $4 by Craig Hallum.</li><li>Flexion Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/FLXN' title='Flexion Therapeutics, Inc.'>FLXN</a>) price target raised to $42 (40% upside) from $36 by Needham following FDA OK of Zilretta. Shares up&nbsp;<font color='green'>5%</font>&nbsp;premarket.</li><li>Humana (NYSE:<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a>) downgraded to Neutral with a $253 (2% upside) price target by JPMorgan.</li><li>DaVita (NYSE:<a href='https://seekingalpha.com/symbol/DVA' title='DaVita HealthCare Partners Inc.'>DVA</a>) downgraded to Underweight by JPMorgan.</li><li>Medtronic (NYSE:<a href='https://seekingalpha.com/symbol/MDT' title='Medtronic plc'>MDT</a>) downgraded to Market Perform by Wells Fargo.</li><li>Hologic (NASDAQ:<a href='https://seekingalpha.com/symbol/HOLX' title='Hologic, Inc.'>HOLX</a>) price target lowered to $45 from $48 by Stilel.</li><li>Achaogen (NASDAQ:<a href='https://seekingalpha.com/symbol/AKAO' title='Achaogen'>AKAO</a>) price target lowered to $22 (44% upside) from $28 by Leerink Partners.</li></ul><div class=\"tiny-share-widget\" data-id=\"3299900\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$WCG $WCG $ALT - Premarket analyst action - healthcare https://seekingalpha.com/news/3299900-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3299900-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3299899\" data-ts=\"1507546442\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXTA\" target=\"_blank\">AXTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3299899-axalta-updates-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axalta updates guidance</a></h4><ul>     <li>Axalta Coating Systems (NYSE:<a href='https://seekingalpha.com/symbol/AXTA' title='Axalta Coating Systems'>AXTA</a>) provides a guidance update to factor in the expected impact of the recent natural       disasters, distributor working capital adjustments in its performance coatings segment and the projected widening of the gap between raw material input costs vs. customer price       increases.</li> <li>Sales for Q3 are expected to be       between $1.08B to $1.10B vs. $1.13B consensus.</li>     <li>The company now expects Q3 adjusted       EBITDA to be in a range of $205M to $215M and full-year EBITDA to be $870M to $900M.</li>     <li>\"We have       seen and expect moderate effects on our business from recent hurricanes       and the earthquake in Mexico, largely in terms of lost near-term volume       opportunity. We believe that much of this impact will be made up during       the course of 2018,\" says CEO Charles Shaver.</li>          <li>Source: <a href=\"https://seekingalpha.com/pr/16962447-axalta-updates-financial-guidance-highlights-recent-effects-business\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3299899\" data-linked=\"Axalta updates guidance\" data-tweet=\"$AXTA - Axalta updates guidance https://seekingalpha.com/news/3299899-axalta-updates-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3299899-axalta-updates-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":55,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}